Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The […]
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The […]
